Current Report Filing (8-k)
11 Mai 2022 - 10:38PM
Edgar (US Regulatory)
0001764046 false 00-0000000 0001764046
2022-05-05 2022-05-05 0001764046 us-gaap:CommonStockMember
2022-05-05 2022-05-05 0001764046
us-gaap:SeriesAPreferredStockMember 2022-05-05 2022-05-05
iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of
1934
Date of report (date of earliest event reported): May 11,
2022 (May
5, 2022)
CLARIVATE PLC
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
(State or other jurisdiction of incorporation or organization)
001-38911
(Commission File Number)
N/A
(I.R.S. Employer Identification
No.)
70 St. Mary Axe
London EC3A 8BE
United Kingdom
(Address of Principal Executive Offices)
(44)
207-433-4000
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
¨ |
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
¨ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Ordinary shares |
|
CLVT |
|
New York Stock Exchange |
5.25% Series A Mandatory Convertible Preferred Shares, no par
value |
|
CLVT PR A |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ¨
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders |
On May 5, 2022, Clarivate Plc (“Clarivate” or the “Company”) held
its 2022 Annual General Meeting of Shareholders. At that meeting,
the shareholders considered and acted upon six proposals pursuant
to the Notice of Annual General Meeting of Shareholders and as
described in more detail in the Company’s definitive proxy
statement dated April 7, 2022 (the "Proxy Statement"). Of
683,575,840 shares outstanding and entitled to vote as of March 7,
2022 (the “Record Date”), the holders of record of 611,629,293
shares were present at the meeting either in person or by proxy.
All proposals on the agenda were approved by the shareholders.
Below are the final voting results.
(1) Shareholders
elected the individuals named below to serve as directors of
Clarivate, with their terms expiring at the Company’s 2023 Annual
General Meeting. Election of each director required approval by a
simple majority of the votes cast by, or on behalf of, the
shareholders entitled to vote in person or represented by
proxy.
Nominee |
For |
Against |
Abstain |
Broker Non-Votes |
Jerre Stead |
586,641,509 |
18,029,156 |
1,226,956 |
5,731,672 |
Valeria Alberola |
589,354,249 |
9,748,939 |
6,794,433 |
5,731,672 |
Michael Angelakis |
576,232,814 |
22,867,865 |
6,796,942 |
5,731,672 |
Jane Okun Bomba |
586,945,412 |
12,157,882 |
6,794,327 |
5,731,672 |
Usama N. Cortas |
595,787,463 |
9,987,073 |
123,085 |
5,731,672 |
Konstantin Gilis |
585,153,604 |
15,427,628 |
5,316,389 |
5,731,672 |
Balakrishnan S. Iyer |
577,546,034 |
21,521,261 |
6,830,326 |
5,731,672 |
Adam T. Levyn |
595,610,888 |
10,170,148 |
116,585 |
5,731,672 |
Anthony Munk |
582,688,257 |
16,414,736 |
6,794,628 |
5,731,672 |
Richard W. Roedel |
563,521,146 |
35,584,348 |
6,792,127 |
5,731,672 |
Andrew Snyder |
597,261,361 |
8,521,180 |
115,080 |
5,731,672 |
Sheryl von Blucher |
587,243,247 |
13,305,169 |
5,349,205 |
5,731,672 |
Roxane White |
590,398,796 |
10,183,082 |
5,315,743 |
5,731,672 |
(2) Shareholders
approved Clarivate’s proposal to engage in open-market share
repurchases of its ordinary shares. Approval required two-thirds of
the votes cast by, or on behalf of, the shareholders entitled to
vote in person or represented by proxy.
For |
527,213,624 |
Against |
78,046,429 |
Abstain |
637,568 |
Broker Non-Votes |
5,731,672 |
(3) Shareholders
approved a proposal to authorize share repurchases of Clarivate’s
ordinary shares from any Shareholder Party to that certain
Registration Rights Agreement with the Company dated as of October
1, 2020, as amended. Approval required both (i) two-thirds of the
votes cast by, or on behalf of, the shareholders entitled to vote
in person or represented by proxy and (ii) a simple majority of the
votes cast by, or on behalf of, the shareholders entitled to vote
in person or represented by proxy, excluding for purposes of this
clause (ii) votes cast by a Shareholder Party with respect to share
repurchases from such Shareholder Party.
|
Votes Cast by All
Shareholders |
For |
534,467,081 |
Against |
70,791,492 |
Abstain |
639,048 |
Broker non-votes |
5,731,672 |
|
Excluding Votes Cast by Atairos
Investors |
For |
532,321,765 |
Against |
70,791,492 |
Abstain |
639,048 |
Broker non-votes |
5,731,672 |
|
Excluding Votes Cast by CIG
Investors |
For |
492,347,910 |
Against |
70,791,492 |
Abstain |
639,048 |
Broker non-votes |
5,731,672 |
|
Excluding Votes Cast by GS
Investors |
For |
533,751,975 |
Against |
70,791,492 |
Abstain |
639,048 |
Broker non-votes |
5,731,672 |
(4) Shareholders
approved Clarivate’s proposal to engage in open-market share
repurchases of its 5.25% Series A Mandatory Convertible Preferred
Shares. Approval required two-thirds of the votes cast by, or on
behalf of, the shareholders entitled to vote in person or
represented by proxy.
For |
520,833,992 |
Against |
79,214,547 |
Abstain |
5,849,082 |
Broker Non-Votes |
5,731,672 |
(5) Shareholders
approved, on an advisory, non-binding basis, the compensation of
the Company’s named executive officers. Approval required at least
a simple majority of the votes cast by, or on behalf of, the
shareholders entitled to vote in person or represented by
proxy.
For |
580,468,952 |
Against |
17,956,289 |
Abstain |
7,472,380 |
Broker non-votes |
5,731,672 |
(6) Shareholders
ratified the appointment of PricewaterhouseCoopers LLP to serve as
Clarivate’s independent registered public accounting firm for 2022.
Ratification required a simple majority of the votes cast by, or on
behalf of, the shareholders entitled to vote in person or
represented by proxy.
For |
609,145,019 |
Against |
2,461,850 |
Abstain |
22,424 |
Date of 2023 Annual General Meeting of Shareholders
Clarivate’s 2023 Annual General Meeting of Shareholders will be
held on May 4, 2023. Further details will be provided in the proxy
statement for the meeting.
|
Item 9.01. |
Financial Statements and Exhibits |
(d) Exhibits.
No. |
|
Description |
|
|
|
104 |
|
The
cover page from this Current Report on Form 8-K formatted in Inline
XBRL |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
CLARIVATE
PLC |
|
|
Date: May 11,
2022 |
By: |
/s/ Jerre Stead |
|
Name: Jerre Stead |
|
Executive Chair and
Chief Executive Officer |
Clarivate (NYSE:CLVT)
Historical Stock Chart
Von Mai 2022 bis Jun 2022
Clarivate (NYSE:CLVT)
Historical Stock Chart
Von Jun 2021 bis Jun 2022